期刊文献+

心脏核素显像对经皮室间隔化学消融术治疗肥厚型梗阻性心肌病的评价 被引量:2

Radionuclide imaging in evaluation of left ventricular perfusion and function after percutaneous translumial septal myocardial ablation in patients with hypertrophic obstructive cardiomyopathy
下载PDF
导出
摘要 目的探讨99Tcm甲氧基异丁基异腈(MIBI)心肌灌注显像和平衡法核素心室显像在经皮室间隔化学消融术(PTSMA)治疗肥厚型梗阻性心肌病的应用价值。方法8例肥厚型梗阻性心肌病患者,于PTSMA术前3~6[平均(4±1)]d和术后7~15[平均(10±3)]d分别行99TcmMIBI静息心肌灌注显像和平衡法核素心室显像。计算室间隔和左心室侧壁放射性比值及室间隔缺损范围,左心室射血分数(LVEF)、高峰充盈率(PFR)和室间隔局部EF。结果8例患者术前心肌灌注显像均显示室间隔放射性浓聚。术后心肌灌注显像示7例部分室间隔放射性缺损,其中1例伴左心室下壁放射性缺损;术后室间隔和左心室侧壁放射性比值明显低于术前(0.76±0.14比1.15±0.11,P<0.01),室间隔缺损范围占左室的(6.42±1.29)%;仅1例室间隔放射性计数无明显变化。术后PFR明显高于术前[(2.29±0.24)EDVs比(1.62±0.28)EDVs,P<0.01],室间隔局部EF明显低于术前[(34±9)%比(57±7)%,P<0.01],但LVEF无明显变化。结论心脏核素显像有助于判断PTSMA所致心肌损害和心室功能变化。 Objective To evaluate the clinical value of ~99 Tcm-methoxyisobutylisonitrile (MIBI) myocardial perfusion imaging (MPI) and equilibrium radionuclide angiography (ERNA) in patients with hypertrophic obstructive cardiomyopathy (HOCM) who underwent percutaneous translumial septal myocardial ablation (PTSMA). Methods Eight patients (5 men, 3 women) with symptomatic HOCM underwent rest ~99 Tcm-MIBI MPI and ERNA before and after PTSMA. The septal-to-lateral counts ratio and the extent of septal perfusion defect of the left ventricle were calculated from MPI. The left ventricular ejection fraction (EF), peak filling rate (PFR) and septal regional EF were measured from ERNA. Results ~99 Tcm-MIBI MPI showed increased septal ~99 Tcm-MIBI uptake before PTSMA in all patients, and septal perfusion defects after PTSMA in 7 patients. The count-activity ratio of the septal-to-lateral wall decreased from 1.15±0.11 to 0.76±0.14 (P<0.01). The defect extent of the left ventricular septum was (6.42±1.29)%. Furthermore, PFR increased significantly from (1.62±0.28) EDV/s before PTSMA to (2.29±0.24) EDV/s after PTSMA (P<0.01). The left ventricular septal regional EF decreased from (57±7)% to (34±9)% (P<0.01). However, left ventricular EF did not change significantly. Conclu-sion MPI and ERNA are useful for the assessment of myocardial pefusion and the change of left ventricular function after PTSMA in patients with HOCM.
出处 《中华核医学杂志》 CAS CSCD 北大核心 2004年第5期281-283,i005,共4页 Chinese Journal of Nuclear Medicine
关键词 心脏核素显像 经皮室间隔化学消融术 治疗 肥厚型梗阻性心肌病 评价 Cardiomyopathy, hypertrophic obstructive Percutaneous translumial septal myocardial ablation Tomography, emission-computed, single-photon MIBI
  • 相关文献

参考文献11

  • 1Mckenna WJ, Camm AJ. Sudden death in hypertrophic cardiomyopathy:assessment of patient at high risk. Circulation, 1989, 80: 1489-1492.
  • 2中华心血管病杂志编委会经皮经腔间隔心肌消融术治疗专题组.经皮经腔间隔心肌消融术治疗的参考意见[J].中华心血管病杂志,2001,29(7):434-435. 被引量:54
  • 3Seggwiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy:acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol,1998, 31: 252-258.
  • 4Nagueh SF, Lakkis NM, He ZX, et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol, 1998, 32: 225-229.
  • 5Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation, 1998, 98: 1750-1755.
  • 6Keng FY, Chang SM, Cwajg E, et al. Gated SPECT hi patients with hypertrophic obstructive cardiomyopathy undergoing transcoronary ethanol septal ablation. J Nucl Cardiol, 2002, 9: 594-600.
  • 7姜腾勇 吴学思 贾长琪 等.心肌灌注显像在肥厚梗阻性心肌病经皮间隔心肌消融术中的应用[J].中华核医学杂志,2000,20:286-286.
  • 8李占全,张明,关汝明,金元哲,张薇薇,楚世文,王效刚,孙玲,程玉海,王丽君,攸翔,王伟.经皮经冠状动脉室间隔化学消融术治疗梗阻性肥厚型心肌病的近期疗效观察[J].中华心血管病杂志,2001,29(1):8-11. 被引量:40
  • 9潘敏,邓又斌,常青,杨好意,毕小军,向慧娟,黎春蕾.定量组织多普勒速度成像对肥厚型心肌病患者左心室局部舒张功能的研究[J].中华超声影像学杂志,2003,12(8):453-456. 被引量:8
  • 10林戟,姚薇萱,常国钧.放射性核素显像评价肥厚型心肌病[J].南京医科大学学报(自然科学版),1996,16(6):549-551. 被引量:1

二级参考文献5

共引文献89

同被引文献41

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部